Ardent Health Partners, Inc. (ARDT) - Net Assets
Based on the latest financial reports, Ardent Health Partners, Inc. (ARDT) has net assets worth $1.73 Billion USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.25 Billion) and total liabilities ($3.52 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ARDT tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.73 Billion |
| % of Total Assets | 32.96% |
| Annual Growth Rate | 17.46% |
| 5-Year Change | 136.71% |
| 10-Year Change | N/A |
| Growth Volatility | 33.36 |
Ardent Health Partners, Inc. - Net Assets Trend (2016–2025)
This chart illustrates how Ardent Health Partners, Inc.'s net assets have evolved over time, based on quarterly financial data. See Ardent Health Partners, Inc. (ARDT) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Ardent Health Partners, Inc. (2016–2025)
The table below shows the annual net assets of Ardent Health Partners, Inc. from 2016 to 2025. For live valuation and market cap data, see Ardent Health Partners, Inc. (ARDT) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $1.68 Billion | +10.68% |
| 2024-12-31 | $1.52 Billion | +40.66% |
| 2023-12-31 | $1.08 Billion | +3.05% |
| 2022-12-31 | $1.05 Billion | +47.55% |
| 2018-12-31 | $711.84 Million | -6.37% |
| 2017-12-31 | $760.28 Million | +91.99% |
| 2016-12-31 | $396.01 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ardent Health Partners, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4257.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $501.61 Million | 29.75% |
| Common Stock | $1.43 Million | 0.08% |
| Other Comprehensive Income | $-3.61 Million | -0.21% |
| Other Components | $1.19 Billion | 70.38% |
| Total Equity | $1.69 Billion | 100.00% |
Ardent Health Partners, Inc. Competitors by Market Cap
The table below lists competitors of Ardent Health Partners, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
WuXi Xinje Electric Co Ltd
SHG:603416
|
$1.28 Billion |
|
COSMO Pharmaceuticals SA
SW:COPN
|
$1.28 Billion |
|
Zhejiang Goldensea Envi Tech C
SHG:603311
|
$1.28 Billion |
|
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161
|
$1.28 Billion |
|
Cobram Estate Olives Ltd
AU:CBO
|
$1.28 Billion |
|
Edelweiss Financial Services Limited
NSE:EDELWEISS
|
$1.28 Billion |
|
Beijing Urban Construction Investment & Development Co Ltd
SHG:600266
|
$1.28 Billion |
|
Thinking Electronic Industrial Co Ltd
TW:2428
|
$1.28 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ardent Health Partners, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,131,376,000 to 1,686,214,000, a change of 554,838,000 (49.0%).
- Net income of 135,811,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 13,347,000.
- Other factors increased equity by 432,374,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $135.81 Million | +8.05% |
| Other Comprehensive Income | $-13.35 Million | -0.79% |
| Other Changes | $432.37 Million | +25.64% |
| Total Change | $- | 49.04% |
Book Value vs Market Value Analysis
This analysis compares Ardent Health Partners, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.75x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.71x to 0.75x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $1.89 | $8.91 | x |
| 2017-12-31 | $2.68 | $8.91 | x |
| 2018-12-31 | $2.35 | $8.91 | x |
| 2022-12-31 | $4.46 | $8.91 | x |
| 2023-12-31 | $4.68 | $8.91 | x |
| 2024-12-31 | $8.52 | $8.91 | x |
| 2025-12-31 | $11.92 | $8.91 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ardent Health Partners, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.05%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.15%
- • Asset Turnover: 1.20x
- • Equity Multiplier: 3.14x
- Recent ROE (8.05%) is above the historical average (2.37%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 5.48% | 0.69% | 1.94x | 4.07x | $-12.05 Million |
| 2017 | -9.44% | -1.19% | 1.26x | 6.29x | $-73.42 Million |
| 2018 | -43.13% | -3.44% | 1.52x | 8.28x | $-176.19 Million |
| 2022 | 29.56% | 3.68% | 1.06x | 7.60x | $125.00 Million |
| 2023 | 7.50% | 0.93% | 1.06x | 7.61x | $-16.80 Million |
| 2024 | 18.59% | 3.53% | 1.20x | 4.38x | $97.21 Million |
| 2025 | 8.05% | 2.15% | 1.20x | 3.14x | $-32.81 Million |
Industry Comparison
This section compares Ardent Health Partners, Inc.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $513,991,152
- Average return on equity (ROE) among peers: -399.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ardent Health Partners, Inc. (ARDT) | $1.73 Billion | 5.48% | 2.03x | $1.28 Billion |
| Acadia Healthcare Company Inc (ACHC) | $1.69 Billion | 7.07% | 1.54x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $970.49 Million | 7.58% | 0.46x | $1.69 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $264.44 Million |
| Airsculpt Technologies Inc (AIRS) | $83.99 Million | -5.33% | 1.43x | $348.50 Million |
| Amedisys Inc (AMED) | $810.74 Million | 22.65% | 0.93x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $819.68 Million | 8.62% | 1.87x | $624.22 Million |
| American Shared Hospital Service (AMS) | $15.99 Million | 6.89% | 1.80x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $108.01 Million | -3.68% | 3.35x | $336.36 Million |
| Astrana Health Inc (ASTH) | $270.37K | -3317.63% | 75.36x | $1.90 Billion |
About Ardent Health Partners, Inc.
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of … Read more